Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms
Crossref DOI link: https://doi.org/10.1038/s12276-021-00649-0
Published Online: 2021-07-12
Published Print: 2021-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kang, Sujin
Kishimoto, Tadamitsu
Text and Data Mining valid from 2021-07-01
Version of Record valid from 2021-07-12
Article History
Received: 27 February 2021
Revised: 27 May 2021
Accepted: 28 May 2021
First Online: 12 July 2021
Competing interests
: T.K. holds a patent for tocilizumab and has received royalties for Actemra.